Company / Total Assets
Yubo International Biotech Ltd Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$847.1K
FY2025
5-year range
$847.1K / $2.4M
FY2021-FY2025
Trend
-44.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $2M in FY2020 to $847,094 in FY2025.
Based on SEC 10-K filings.
$847,094 in FY2025 with a 5-year CAGR of -19.1%.
Declined from $2M to $847,094 over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -28.8%
- 5-Year CAGR
- -19.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Yubo International Biotech Ltd's total assets has declined for 4 consecutive years.
- 5-year CAGR of -19.1%, indicating a declining trend.
- In FY2025, total assets decreased 44.8% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $847.1K | -44.8% |
| FY2024 | $1.5M | -7.9% |
| FY2023 | $1.7M | -29.0% |
| FY2022 | $2.3M | -3.9% |
| FY2020 | $2.4M | +61021.9% |
| FY2019 | $4.0K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |